Trademark: 97673066
Word
CISLEUKIN
Status Date
Friday, May 10, 2024
Filing Date
Friday, November 11, 2022
Published for Opposition
Tuesday, October 24, 2023
42 Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals
The wording "CISLEUKIN" has no meaning in a foreign language.
Nov 15, 2022
New Application Entered
Dec 2, 2022
New Application Office Supplied Data Entered
Aug 25, 2023
Assigned To Examiner
Aug 26, 2023
Non-Final Action Written
Aug 26, 2023
Non-Final Action E-Mailed
Aug 26, 2023
Notification Of Non-Final Action E-Mailed
Sep 15, 2023
Examiners Amendment -Written
Sep 15, 2023
Examiners Amendment E-Mailed
Sep 15, 2023
Notification Of Examiners Amendment E-Mailed
Sep 15, 2023
Examiner's Amendment Entered
Sep 15, 2023
Approved For Pub - Principal Register
Oct 4, 2023
Notification Of Notice Of Publication E-Mailed
Oct 24, 2023
Published For Opposition
Oct 24, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Noa E-Mailed - Sou Required From Applicant
May 10, 2024
Sou Extension 1 Filed
May 10, 2024
Sou Teas Extension Received
May 10, 2024
Sou Extension 1 Granted
May 11, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 13, 2024
Automatic Update Of Assignment Of Ownership
Trademark Alertz updated from USPTO on 2030-01-24
